An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

Research Site, Alabaster

Research Site, Mobile

Research Site, Tucson

Research Site, North Little Rock

Research Site, Anaheim

Research Site, Orange

Research Site, Torrance

Research Site, Miami

Research Site, Ocoee

Research Site, Tampa

Research Site, Zephyrhills

Research Site, Arlington Heights

Research Site, New Orleans

Research Site, Shreveport

Research Site, Hollywood

Research Site, Elkin

Research Site, Oklahoma City

Research Site, Chattanooga

Research Site, Knoxville

Research Site, Austin

Research Site, Houston

Research Site, Ogden

Research Site, Salt Lake City

Research Site, Christiansburg

Research Site, Norfolk